Rolf F Kletzien

Title: Rolf F Kletzien: Innovator in Medical Research

Introduction

Rolf F Kletzien is a notable inventor based in Plainwell, MI (US). He has made significant contributions to the field of medical research, particularly in the development of novel therapeutic agents. With a total of 2 patents, Kletzien's work focuses on innovative solutions for health-related challenges.

Latest Patents

Kletzien's latest patents include groundbreaking inventions. The first patent, titled "Human caspase-12 materials and methods," provides novel human caspase-12 polynucleotides and polypeptides. This invention includes constructs and recombinant host cells incorporating the polynucleotides, as well as antibodies to the polypeptides and methods of making and using all of the foregoing. The second patent, "4-hydroxycoumarin-3-carboxamides for the treatment of diabetes mellitus," presents novel 4-hydroxycoumarin-3-carboxamide derivatives. This invention aims to treat patients suffering from or susceptible to diabetes mellitus.

Career Highlights

Kletzien is associated with Pharmacia & Upjohn Company, where he has contributed to various research initiatives. His work has been instrumental in advancing medical treatments and understanding complex biological processes.

Collaborations

Kletzien has collaborated with notable colleagues, including Ilene M Reardon and Katherine L Weiland. These partnerships have fostered innovation and enhanced the impact of their research efforts.

Conclusion

Rolf F Kletzien's contributions to medical research through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in healthcare solutions.